Shanghai Community Cohort Establishment and Follow-up
1 other identifier
observational
80,000
1 country
1
Brief Summary
Our objective is to establish a natural population cohort in East China based on the latest scientific researches, preliminary findings of the project team, and a close cooperation model of the Specialist Medical Consortium. Firstly, we will focus on the information and management status of high-risk, single-patient, and co-occurring patient groups of cardio cerebral diseases such as coronary heart disease and stroke. We plan to integrate the questionnaire data and sample database information into the cardio-cerebral "co-prevention and management" information platform, in order to establish a cardiovascular and cerebrovascular disease management system. Secondly, we aim to develop a new risk prediction model for heart and brain diseases based on the big data platform, lead the establishment of the "co-prevention and management" innovation management model for cardio cerebral diseases, and explore an integrated and innovative health management model for the prevention and treatment of cardio cerebral diseases for China.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 7, 2019
CompletedFirst Submitted
Initial submission to the registry
August 16, 2020
CompletedFirst Posted
Study publicly available on registry
August 18, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJuly 11, 2023
July 1, 2023
6.4 years
August 16, 2020
July 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cardiovascular and Cerebrovascular incidence
Incidence of Cardiovascular and Cerebrovascular disease were calculated by age, gender and area compared by different health management mode.
5 years
Cardiovascular and Cerebrovascular mortality
Mortality of Cardiovascular and Cerebrovascular disease were calculated by age, gender and area compared by different health management mode.
5 years
Secondary Outcomes (1)
Normalized management rate of Cardiovascular and Cerebrovascular disease
5 years
Eligibility Criteria
Eligible residents from second-class medical units and community health service centers with mature conditions.
You may qualify if:
- Patients \>= 35y
- Registered Permanent residents or have lived for more than 5 years and have local social security medical insurance
- Patients with no serious physical disability and can communicate normally
- Patients who participate voluntarily and sign informed consent
- Patients whose diseases and deaths are managed by the local health department
You may not qualify if:
- Temporary residents and floating population
- Patients with serious health conditions and cannot participate in the investigation
- Patients who are unwilling to accept follow-up inspections of the project
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- RenJi Hospitallead
- Jinqiao Community Health Service Center of Pudong new area, Shanghaicollaborator
- Heqing Community Health Service Center of Pudong new area, Shanghaicollaborator
- Weifang Community Health Service Center of Pudong new area, Shanghaicollaborator
- Jinyang Community Health Service Center of Pudong new area, Shanghaicollaborator
Study Sites (1)
Ren Ji Hospital Afflited to School of Medicine, Shanghai Jiao Tong University
Shanghai, Shanghai Municipality, 200000, China
Biospecimen
Biological specimen collection: collect 10ml ethylenediaminetetraacetic acid blood samples using a health checkup, then send them to renji sample bank for separation within 2 hours, and store in -80℃ ultra-low temperature refrigerator.
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Jun Pu, MD,PhD
RenJi Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Cardiovascular Medicine
Study Record Dates
First Submitted
August 16, 2020
First Posted
August 18, 2020
Study Start
August 7, 2019
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
July 11, 2023
Record last verified: 2023-07